Caffeine 2.17 MG/ML / choline salicylate 29 MG/ML Oral Solution — RxCUI 1994320
RxNorm drug concept · Semantic clinical drug
RxCUI 1994320
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1994320
Official nameCaffeine 2.17 MG/ML / choline salicylate 29 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascaffeine 65 MG / choline salicylate 870 MG per 30 ML Oral Solution; caffeine 65 MG / choline salicylate 870 MG in 30 mL Oral Solution
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Caffeine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Caffeine citrate is a prescription medicine given in the hospital to premature babies who have apnea of prematurity — that means they sometimes stop breathing for short periods, wh...
- What exactly is caffeine citrate used for in babies, and is it safe?
- The medical team will be monitoring your baby closely, but it helps to know the signs to watch for. The most serious concern is necrotizing enterocolitis (NEC) — a severe intestina...
- What side effects should I watch for in my premature baby on caffeine citrate?
🕸️ Concept Web — How Caffeine 2.17 MG/ML / choline salicylate 29 MG/M... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Caffeine 2.17 MG/ML / choline salicylate 29 MG/ML Oral Solution
RxCUI 1994320 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 4
The active substance itself — no strength, form, or brand attached yet.
-
Caffeine
1886IN -
Choline
2449IN -
Caffeine / choline
1436556MIN -
Choline salicylate
20974PIN
-
Caffeine
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Caffeine / choline Oral Solution
1436555SCDF -
Caffeine / choline salicylate Oral Solution
2648217SCDFP -
Caffeine / choline Oral Liquid Product
1436553SCDG -
Caffeine / choline Oral Product
1436554SCDG -
Caffeine / choline salicylate Oral Liquid Product
2659724SCDGP -
Caffeine / choline salicylate Oral Product
2662036SCDGP -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Caffeine / choline Oral Solution
-
Clinical & branded drugs 2
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Caffeine 2.17 MG/ML
1994319SCDC -
Choline salicylate 29 MG/ML
1653128SCDC
-
Caffeine 2.17 MG/ML
Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Caffeine 2.17 MG/ML
SCDC · 1994319 -
Choline salicylate 29 MG/ML
SCDC · 1653128 -
Caffeine / choline Oral Solution
SCDF · 1436555 -
Caffeine / choline salicylate Oral Solution
SCDFP · 2648217 -
Caffeine / choline Oral Liquid Product
SCDG · 1436553 -
Caffeine / choline Oral Product
SCDG · 1436554 -
Caffeine / choline salicylate Oral Liquid Product
SCDGP · 2659724 -
Caffeine / choline salicylate Oral Product
SCDGP · 2662036
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 1994320 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 58809-0389-08 | 237 mL in 1 BOTTLE (58809-389-08) | TEXACLEAR PAIN RELIEVER | GM Pharmaceuticals, INC | 2017-12-14 |
Observed labelers:
GM Pharmaceuticals, INC (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.